Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease.

Related Articles:

• Neuroprotective and Antioxidant Effect of Naringenin-Loaded Nanoparticles for Nose-to-Brain Delivery. October 18, 2019 Related ArticlesNeuroprotective and Antioxidant Effect of Naringenin-Loaded Nanoparticles for Nose-to-Brain Delivery. Brain Sci. 2019 Oct 15;9(10): Authors: Md S, Alhakamy NA, Aldawsari HM, Asfour HZ Abstract Parkinson's disease (PD) is a neurodegenerative disorder resulting in a decreased nigrostriatal availability of dopamine. Oxidative stress is one factor contributing to PD. Naringenin (NAR), a flavonoid, is a potent antioxidant shown to be…
• Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment? October 31, 2019 Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment? Expert Opin Drug Deliv. 2019 Oct 30;: Authors: Rehman S, Nabi B, Zafar A, Baboota S, Ali J Abstract Introduction: Intranasal drug delivery is a largely unexplored, promising approach for the treatment of various neurological disorders. However, due to the challenging constraints available in the pathway of nose-to-brain…
• AMPK mediates the neurotoxicity of iron oxide nanoparticles retained in mitochondria or lysosomes. June 27, 2019 AMPK mediates the neurotoxicity of iron oxide nanoparticles retained in mitochondria or lysosomes. Metallomics. 2019 Jun 26;: Authors: Huang H, Zhou M, Ruan L, Wang D, Lu H, Zhang J, Chen J, Hu Y, Chai Z Abstract Environmental factors may play a critical role in the etiology and pathogenesis of Parkinson's disease (PD). However, the association of PD with specific…
• Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease. October 23, 2019 Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease. ACS Appl Mater Interfaces. 2019 Oct 22;: Authors: Chen T, Liu W, Xiong S, Li D, Fang S, Wu Z, Wang Q, Chen X Abstract Recent work has highlighted the potential of puerarin (PU) as a valuable compound to treat Parkinson's disease (PD), but its poor…
• Role of nanostructures in improvising oral medicine. May 14, 2019 Related ArticlesRole of nanostructures in improvising oral medicine. Toxicol Rep. 2019;6:358-368 Authors: Ghosh S, Ghosh S, Sil PC Abstract The most preferable mode of drugs administration is via the oral route but physiological barriers such as pH, enzymatic degradation etc. limit the absolute use of this route. Herein lies the importance of nanotechnology having a wide range of applications in…
• The role of pramipexole functionalized MWCNTs to the fabrication of Pd nanoparticles modified GCE for electrochemical detection of dopamine. July 19, 2019 The role of pramipexole functionalized MWCNTs to the fabrication of Pd nanoparticles modified GCE for electrochemical detection of dopamine. Daru. 2019 Jul 17;: Authors: Baghayeri M, Nodehi M, Veisi H, Tehrani MB, Maleki B, Mehmandost M Abstract BACKGROUND: Interest in functionalized carbon nanotubes for many applications arises from a variety on the kind of modification atoms or molecules that are…
• Microelectrode Arrays Modified with Nanocomposites for Monitoring Dopamine and Spike Firings Under Deep Brain Stimulation in Rat Models of Parkinson's Disease. July 6, 2019 Related ArticlesMicroelectrode Arrays Modified with Nanocomposites for Monitoring Dopamine and Spike Firings Under Deep Brain Stimulation in Rat Models of Parkinson's Disease. ACS Sens. 2019 Jul 05;: Authors: Xiao G, Song Y, Zhang Y, Xing Y, Zhao HY, Xie J, Xu S, Gao F, Wang M, Xing GG, Cai X Abstract Little is known about the efficacy of Deep Brain…
• Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson's disease. March 29, 2019 Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson's disease. J Pharmacol Exp Ther. 2019 Mar 27;: Authors: Howson PA, Johnston TH, Ravenscroft P, Hill MP, Su J, Brotchie JM, Koprich JB Abstract Disease modification in Parkinson's disease (PD) is an unmet medical need. In the current study, we evaluated trehalose, a…
• Tiny Vesicles Found in Blood Able to Carry Dopamine into Brains of Mice in Parkinson’s Study September 5, 2018 Tiny fatty vesicles that naturally circulate in the blood can effectively carry medications into the central nervous system, including into the brain, an early study in mice suggests. These blood vesicles, called exosomes, were able to successfully deliver dopamine directly to specific areas of the brain affected by Parkinson’s disease. The study, “Dopamine-loaded blood exosomes targeted to brain for better treatment…
• Ultrasound-assisted synthesis of α-MnS (alabandite) nanoparticles decorated reduced graphene oxide hybrids: Enhanced electrocatalyst for electrochemical detection of Parkinson's disease biomarker. May 19, 2019 Related ArticlesUltrasound-assisted synthesis of α-MnS (alabandite) nanoparticles decorated reduced graphene oxide hybrids: Enhanced electrocatalyst for electrochemical detection of Parkinson's disease biomarker. Ultrason Sonochem. 2019 Sep;56:378-385 Authors: Chen TW, Rajaji U, Chen SM, Li YL, Ramalingam RJ Abstract Herein, novel manganese sulfide nanoparticles (MnS NPs) decorated reduced graphene oxide (rGOS) nanocomposite have been designed through a facile ultrasound-assisted method and followed…
• Nanoparticles may cause DNA damage to brain cells across a cellular barrier April 4, 2018 (Trinity College Dublin) New research by scientists shows that when cellular barriers are exposed to metal nanoparticles, cellular messengers are released that may cause damage to the DNA of developing brain cells. The discovery may have implications for the development of potential drug targets in the treatment of neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease.
• Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson's Disease Model. May 22, 2019 Related ArticlesVitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson's Disease Model. Biomed Res Int. 2019;2019:2382563 Authors: Gaba B, Khan T, Haider MF, Alam T, Baboota S, Parvez S, Ali J Abstract Purpose: The present study is an attempt to develop a vitamin E loaded naringenin (NRG) Nanoemulsion (NE) for direct…
• Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. October 23, 2019 Related ArticlesTargeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther. 2019;4:33 Authors: Singh AP, Biswas A, Shukla A, Maiti P Abstract The application of nanomedicines is increasing rapidly with the promise of targeted and efficient drug delivery. Nanomedicines address the shortcomings of conventional therapy, as evidenced by several preclinical and clinical investigations indicating site-specific drug…
• Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease. October 20, 2019 Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease. Neurosci Lett. 2019 Oct 16;:134567 Authors: Fine JM, Stroebel BM, Faltesek KA, Terai K, Haase L, Knutzen KE, Kosyakovsky J, Bowe TJ, Fuller AK, Frey WH, Hanson LR Abstract Emerging evidence continues to demonstrate that disrupted insulin signaling and altered…
• Nanodelivery of therapeutic agents in Parkinson's disease. April 10, 2019 Related ArticlesNanodelivery of therapeutic agents in Parkinson's disease. Prog Brain Res. 2019;245:263-279 Authors: Lafuente JV, Requejo C, Ugedo L Abstract Parkinson's disease (PD) as a motor disorder is pathologically featured by the loss of dopaminergic neurons of the substantia nigra compacta (SNc) and the consequent depletion of dopamine in the striatum. However, motor signs are detectable when the loss of…
• Chitosan Nanoparticles Rescue Rotenone-Mediated Cell Death. April 14, 2019 Related ArticlesChitosan Nanoparticles Rescue Rotenone-Mediated Cell Death. Materials (Basel). 2019 Apr 11;12(7): Authors: Ahlawat J, Deemer EM, Narayan M Abstract The aim of the present investigation was to study the anti-oxidant effect of chitosan nanoparticles on a human SH-SY5Y neuroblastoma cell line using a rotenone model to generate reactive oxygen species. Chitosan nanoparticles were synthesized using an ionotropic gelation method.…
• Rabies Virus May Hold Key for Efficient Therapies in Parkinson’s, Study Suggests May 4, 2018 New nanoparticles containing a specific part of the rabies virus may improve brain-targeting therapy in Parkinson’s patients, study suggests. The research, “Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice,” was published in the journal ACS Nano. A common feature of Parkinson’s is the accumulation of iron in the brain, which causes oxidative…
• MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling. August 17, 2019 Related ArticlesMPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling. Psychopharmacology (Berl). 2019 Aug 15;: Authors: Fujita A, Fujita Y, Pu Y, Chang L, Hashimoto K Abstract RATIONALE: Parkinson's disease (PD) is characterized as a chronic and progressive neurodegenerative disorder, and PD patients have non-motor features such as depressive symptoms.…
• Oral Silica Nanoparticles Lack of Neurotoxic Effects in a Parkinson's Disease Model: a Possible Nanocarrier? August 10, 2019 Oral Silica Nanoparticles Lack of Neurotoxic Effects in a Parkinson's Disease Model: a Possible Nanocarrier? IEEE Trans Nanobioscience. 2019 Aug 08;: Authors: Guzman-Ruiz MA, de la Mora MB, Torres X, Meza C, Garcia E, Chavarria A Abstract Silica nanoparticles (SiO2-NP) are an option as drug carriers due to their biodegradability, biocompatibility, and capacity to bind themselves to other compounds. However,…
• An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [18F]FP-(+)-DTBZ. June 6, 2019 Related ArticlesAn Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [18F]FP-(+)-DTBZ. Mol Imaging Biol. 2019 Jun 04;: Authors: Zhao C, Liu C, Tang J, Xu Y, Xie M, Chen Z Abstract PURPOSE: The aim of this study was to optimize the radiolabeling method of [18F]fluoropropyl-(+)-dihydrotetrabenazine ([18F]FP-(+)-DTBZ) to fulfill the demand of preclinical and clinical application. PROCEDURES: Optimized labeling conditions…